Opioid Overdose Market to Exhibit Moderate Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Key Companies – Purdue Pharma, Orexo, Quivivepharma, Adapt Pharma, Indivior
DelveInsight’s “Opioid Overdose Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Opioid Overdose market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The report covers emerging Opioid Overdose drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Opioid Overdose treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Opioid Overdose: An Overview
An opioid overdose can be identified by a combination of three signs and symptoms, referred to as the “opioid overdose triad”. The symptoms of the triad are pinpoint pupil, unconsciousness, and respiratory depression.
Opioids have the potential to cause substance dependence that is characterized by a strong desire to take opioids, impaired control over opioid use, persistent opioid use despite harmful consequences, a higher priority given to opioid use than to other activities and obligations, increased tolerance, and a physical withdrawal reaction when opioids are discontinued.
Opioid analgesic overdose is a preventable and potentially lethal condition that results from prescribing practices, inadequate understanding of the patient’s part of the risks of medication misuse, errors in drug administration, and pharmaceutical abuse. Extensive research and development activities of pharmaceutical companies for developing therapies for Opioid Overdose will significantly impact the market.
Opioid Overdose Market Key Facts
-
According to the CDC, around 68% of the more than 70,200 drug overdose deaths in 2017 involved an opioid.
-
According to World Health Organization (WHO), the incidence of fatal opioid overdose among opioid-dependent individuals is estimated at 0.65% per year. Non-fatal overdoses are several times more common than fatal opioid overdoses. About 45% of drug users experience nonfatal overdose and about 70% witness drug overdose (including fatal) during their lifetime.
-
The study conducted by Van Amsterdam J et al. estimates that in the U.S. prescribed opioids became the second most prevalent type of abused drug (4.5 million abusers; 1.7% of the population) after marijuana (8 million abusers) with currently 1.9 million (0.7% of the population) people dependent on opioid pain relievers.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Opioid Overdose pipeline therapies. It also thoroughly assesses the Opioid Overdose market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the market trend for each marketed Opioid Overdose drugs and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Opioid Overdose Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted Opioid Overdose epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Opioid Overdose epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders.
The Report Covers the Opioid Overdose Epidemiology, Segmented as –
-
Total Prevalent Cases in 7MM (2019–2032)
-
Gender-Specific Prevalent Cases of Opioid Overdose in 7MM (2019–2032)
-
Diagnosed and Treatable Cases of Opioid Overdose in the 7MM (2019–2032)
-
Age-Specific Prevalent Cases of Opioid Overdose in the 7MM (2019–2032)
Opioid Overdose Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Opioid Overdose market or expected to be launched during the study period. The analysis covers the Opioid Overdose market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares the Opioid Overdose drugs based on their sale and market share.
The report also covers the Opioid Overdose pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Opioid Overdose companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How the Opioid Overdose Market Will Evolve and Grow by 2032 @
https://www.delveinsight.com/sample-request/opioid-overdose-market
Opioid Overdose Companies Actively Working in the Therapeutics Market Include
-
Purdue Pharma
-
Orexo
-
Quivivepharma
-
Adapt Pharma
-
Indivior Inc
And Many Others
Emerging and Marketed Opioid Overdose Therapies Covered in the Report Include:
-
Revex
-
OX124
-
QEV-817
-
Narcan
-
Sublocade
And Many More
The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @
https://www.delveinsight.com/sample-request/opioid-overdose-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Opioid Overdose Competitive Intelligence Analysis
4. Opioid Overdose Market Overview at a Glance
5. Opioid Overdose Disease Background and Overview
6. Opioid Overdose Patient Journey
7. Opioid Overdose Patient Population and Epidemiology Trends (In the US, EU5, and Japan)
8. Opioid Overdose Treatment Algorithm, Current Treatment, and Medical Practices
9. Opioid Overdose Unmet Needs
10. Key Endpoints of Opioid Overdose Treatment
11. Opioid Overdose Marketed Therapies
12. Opioid Overdose Emerging Drugs and Latest Therapeutic Advances
13. Opioid Overdose Seven Major Market Analysis
14. Attribute Analysis
15. Opioid Overdose Market Outlook (In US, EU5, and Japan)
16. Opioid Overdose Companies Active in the Market
17. Opioid Overdose Access and Reimbursement Overview
18. KOL Views on the Opioid Overdose Market
19. Opioid Overdose Market Drivers
20. Opioid Overdose Market Barriers
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/opioid-overdose-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
“Hypercalcemia Market Insights, Epidemiology, and Market Forecast-2032” report deliver an in-depth understanding of the historical and forecasted epidemiology as well as the Hypercalcemia market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Moreover, it also covers the current treatment practices, emerging drugs, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Hypercalcemia market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
, Investigates DelveInsight | Key Companies – Purdue Pharma, Orexo, Quivivepharma, Adapt Pharma, Indivior){kind=link}